Booster Vaccination in Infancy Reduces the Incidence of Occult HBV Infection in Maternal HBsAg-positive Children

Yi Li1,2, Lili Li1, Yarong Song1

  • 1Department of Microbiology & Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

Insights

A hepatitis B vaccine (HepB) booster in infancy significantly reduced occult hepatitis B infection (OBI) in children born to mothers with hepatitis B surface antigen. This booster dose improved HBV DNA negative conversion rates by age eight.

Area of Science:

  • Hepatology
  • Immunology
  • Pediatrics

Background:

  • Occult hepatitis B infection (OBI) in children is linked to immune responses after hepatitis B vaccine (HepB) administration.
  • The impact of HepB boosters on OBI in children is not well-documented.

Purpose of the Study:

  • To investigate the effect of a booster HepB dose on OBI incidence in children born to HBsAg-positive mothers.
  • To analyze the long-term outcomes of OBI in relation to vaccination status.

Main Methods:

  • A cohort of 236 children born to HBsAg-positive mothers were followed until age 8.
  • Children were categorized into a booster group (100 received HepB between 1-3 years) and a non-booster group (136).
  • Serial follow-up data and maternal baseline data were collected for comparative analysis.

Main Results:

  • OBI incidence fluctuated dynamically, with varying rates observed throughout the follow-up period.
  • At 8 years, the booster group showed a significantly higher HBV DNA negative conversion rate (57.89%) compared to the non-booster group (30.51%, p=0.032).
  • For children without OBI at 7 months, the booster group had a significantly lower OBI incidence (25.64%) than the non-booster group (67.74%, p<0.001).

Conclusions:

  • Maternal HBsAg positivity is associated with a high incidence of OBI in children.
  • Serum HBV DNA levels in children with OBI are intermittently positive and at low levels.
  • A booster HepB dose in infancy is effective in reducing OBI incidence in children born to HBsAg-positive mothers.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
392
Vaccinations01:51

Vaccinations

Overview
45.0K
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
1.6K
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
1.3K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
664
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.6K